Babu Yarlagadda S
- SEC CIK
- 0001452635
No open-market purchases or sales filed in the past year.
Current role at each company
- BCRX Biocryst Pharmaceuticals IncChief Discovery Officeras of Nov 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Babu Yarlagadda S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2022 (view filing) | Nov 14 | 2 days | Babu Yarlagadda SChief Discovery Officer | SSale | −31.5K | $13.88 | −$437.4K | −9.5%298.5K after | |
| Mar 9, 2022 (view filing) | Mar 7 | 2 days | Babu Yarlagadda SChief Discovery Officer | SSale | −20.0K | $17.16 | −$343.2K | −8.0%230.1K after | |
| Dec 9, 2021 (view filing) | Dec 7 | 2 days | Babu Yarlagadda SChief Discovery Officer | SSale | −30.1K | $12.20 | −$367.2K | −12.3%215.1K after |